- Home
- SRFM vs BDTX Comparison
SRFM vs BDTX Comparison
Compare SRFM & BDTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SRFM
- BDTX
- Stock Information
- Founded
- SRFM 2011
- BDTX 2014
- Country
- SRFM United States
- BDTX United States
- Employees
- SRFM N/A
- BDTX N/A
- Industry
- SRFM Transportation Services
- BDTX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- SRFM Consumer Discretionary
- BDTX Health Care
- Exchange
- SRFM Nasdaq
- BDTX Nasdaq
- Market Cap
- SRFM 199.2M
- BDTX 181.4M
- IPO Year
- SRFM 2023
- BDTX 2020
- Fundamental
- Price
- SRFM $4.45
- BDTX $2.76
- Analyst Decision
- SRFM Buy
- BDTX Strong Buy
- Analyst Count
- SRFM 4
- BDTX 5
- Target Price
- SRFM $5.56
- BDTX $13.40
- AVG Volume (30 Days)
- SRFM 4.1M
- BDTX 914.3K
- Earning Date
- SRFM 08-12-2025
- BDTX 08-07-2025
- Dividend Yield
- SRFM N/A
- BDTX N/A
- EPS Growth
- SRFM N/A
- BDTX N/A
- EPS
- SRFM N/A
- BDTX 0.25
- Revenue
- SRFM $107,372,000.00
- BDTX $70,000,000.00
- Revenue This Year
- SRFM N/A
- BDTX N/A
- Revenue Next Year
- SRFM $62.23
- BDTX N/A
- P/E Ratio
- SRFM N/A
- BDTX $11.03
- Revenue Growth
- SRFM N/A
- BDTX N/A
- 52 Week Low
- SRFM $0.90
- BDTX $1.20
- 52 Week High
- SRFM $9.91
- BDTX $6.75
- Technical
- Relative Strength Index (RSI)
- SRFM 48.99
- BDTX 52.31
- Support Level
- SRFM $3.94
- BDTX $2.22
- Resistance Level
- SRFM $5.54
- BDTX $2.84
- Average True Range (ATR)
- SRFM 0.45
- BDTX 0.20
- MACD
- SRFM -0.04
- BDTX -0.01
- Stochastic Oscillator
- SRFM 34.73
- BDTX 72.00
About SRFM Surf Air Mobility Inc.
Surf Air Mobility Inc provides a regional air mobility platform to connect communities sustainably. The company is an electric aviation and air travel company expanding the category of regional air travel and reinventing flying through electrification. The company is building a regional air mobility ecosystem to sustainably connect the world's communities. It generates revenue through air mobility services.
About BDTX Black Diamond Therapeutics Inc.
Black Diamond Therapeutics Inc is a clinical-stage oncology company developing MasterKey therapies that target families of oncogenic mutations in patients with cancer. It is engaged in the discovery and development of small molecule, tumor-agnostic therapies. The company has one pipeline technology platform, namely Mutation-Allostery-Pharmacology, which is targeting mutations in cancer. Its drugs under the pipeline are BDTX-4933 and BDTX-1535.